VU Med Center couples EMR, genetics

Vanderbilt University Medical Center's PREDICT program detects a genotype that could foul-up patients' treatment and provides an electronic medical record alert. VUMC Reporter here. Related story on Grand Opportunities funding, here.

NellOne Therapeutics licenses from UT-Battelle

Knoxville-based NellOne Therapeutics has licensed patents covering inventions based on the Nell-1 gene. The IP is driving protein therapy treatment now under development and takes advantage of the gene's cell-signaling pathway, which controls tissue growth and maturation in mammalian organs. It could mean restorative therapies for hearts and other muscles. Our story's here.

Computer Genomix targets TNInvestcos

With genetic research all the rage, Memphis-based Computer Genomix sets out tomorrow to tap Nashville-based TNInvestcos for capital. Read the story here.